BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 17452521)

  • 1. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity.
    Boos MD; Yokota Y; Eberl G; Kee BL
    J Exp Med; 2007 May; 204(5):1119-30. PubMed ID: 17452521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development.
    Schotte R; Dontje W; Nagasawa M; Yasuda Y; Bakker AQ; Spits H; Blom B
    J Immunol; 2010 Jun; 184(12):6670-9. PubMed ID: 20483740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development.
    Zook EC; Li ZY; Xu Y; de Pooter RF; Verykokakis M; Beaulieu A; Lasorella A; Maienschein-Cline M; Sun JC; Sigvardsson M; Kee BL
    Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29703840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.
    Ikawa T; Fujimoto S; Kawamoto H; Katsura Y; Yokota Y
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5164-9. PubMed ID: 11296270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15.
    Delconte RB; Shi W; Sathe P; Ushiki T; Seillet C; Minnich M; Kolesnik TB; Rankin LC; Mielke LA; Zhang JG; Busslinger M; Smyth MJ; Hutchinson DS; Nutt SL; Nicholson SE; Alexander WS; Corcoran LM; Vivier E; Belz GT; Carotta S; Huntington ND
    Immunity; 2016 Jan; 44(1):103-115. PubMed ID: 26795246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of novel Id2 and E2-2, E2A and HEB antibodies reveals novel Id2 binding partners and species-specific expression of E-proteins in NK cells.
    Rautela J; Dagley LF; Kratina T; Anthony A; Goh W; Surgenor E; Delconte RB; Webb AI; Elwood N; Groom JR; Souza-Fonseca-Guimaraes F; Corcoran L; Huntington ND
    Mol Immunol; 2019 Nov; 115():56-63. PubMed ID: 30144957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages.
    Tachibana M; Tenno M; Tezuka C; Sugiyama M; Yoshida H; Taniuchi I
    J Immunol; 2011 Feb; 186(3):1450-7. PubMed ID: 21178013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced expression of Id2 in fetal thymic T cell progenitors allows some of their progeny to adopt NK cell fate.
    Fujimoto S; Ikawa T; Kina T; Yokota Y
    Int Immunol; 2007 Oct; 19(10):1175-82. PubMed ID: 17698981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ID2 and ID3 are indispensable for Th1 cell differentiation during influenza virus infection in mice.
    Han X; Liu H; Huang H; Liu X; Jia B; Gao GF; Zhang F
    Eur J Immunol; 2019 Mar; 49(3):476-489. PubMed ID: 30578645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.
    Yokota Y; Mansouri A; Mori S; Sugawara S; Adachi S; Nishikawa S; Gruss P
    Nature; 1999 Feb; 397(6721):702-6. PubMed ID: 10067894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins.
    Ji M; Li H; Suh HC; Klarmann KD; Yokota Y; Keller JR
    Blood; 2008 Aug; 112(4):1068-77. PubMed ID: 18523151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.
    Gascoyne DM; Long E; Veiga-Fernandes H; de Boer J; Williams O; Seddon B; Coles M; Kioussis D; Brady HJ
    Nat Immunol; 2009 Oct; 10(10):1118-24. PubMed ID: 19749763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.
    Spits H; Couwenberg F; Bakker AQ; Weijer K; Uittenbogaart CH
    J Exp Med; 2000 Dec; 192(12):1775-84. PubMed ID: 11120774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine thymic NK cells: A case of identity.
    Male V; Brady HJM
    Eur J Immunol; 2017 May; 47(5):797-799. PubMed ID: 28485520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.
    Male V; Nisoli I; Kostrzewski T; Allan DS; Carlyle JR; Lord GM; Wack A; Brady HJ
    J Exp Med; 2014 Apr; 211(4):635-42. PubMed ID: 24663216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation.
    Masson F; Minnich M; Olshansky M; Bilic I; Mount AM; Kallies A; Speed TP; Busslinger M; Nutt SL; Belz GT
    J Immunol; 2013 May; 190(9):4585-94. PubMed ID: 23536629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine natural killer cell progenitors and their requirements for development.
    Lian RH; Kumar V
    Semin Immunol; 2002 Dec; 14(6):453-60. PubMed ID: 12457618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements.
    Gabrielli S; Sun M; Bell A; Zook EC; de Pooter RF; Zamai L; Kee BL
    Eur J Immunol; 2017 May; 47(5):800-805. PubMed ID: 28276053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development.
    Miyazaki M; Miyazaki K; Chen K; Jin Y; Turner J; Moore AJ; Saito R; Yoshida K; Ogawa S; Rodewald HR; Lin YC; Kawamoto H; Murre C
    Immunity; 2017 May; 46(5):818-834.e4. PubMed ID: 28514688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: Thymic NK cells develop independently from T cell precursors.
    Ribeiro VS; Hasan M; Wilson A; Boucontet L; Pereira P; Lesjean-Pottier S; Satoh-Takayama N; Di Santo JP; Vosshenrich CA
    J Immunol; 2010 Nov; 185(9):4993-7. PubMed ID: 20889548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.